The Veoneer (NYSE:VNE) Share Price Is Down 57% So Some Shareholders Are Wishing They Sold

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Investing in stocks comes with the risk that the share price will fall. And there’s no doubt that Veoneer, Inc. (NYSE:VNE) stock has had a really bad year. The share price has slid 57% in that time. Because Veoneer hasn’t been listed for many years, the market is still learning about how the business performs. The falls have accelerated recently, with the share price down 31% in the last three months.

View our latest analysis for Veoneer

Veoneer isn’t a profitable company, so it is unlikely we’ll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually expect strong revenue growth. That’s because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

Veoneer’s revenue didn’t grow at all in the last year. In fact, it fell 8.8%. That’s not what investors generally want to see. In the absence of profits, it’s not unreasonable that the share price fell 57%. Having said that, if growth is coming in the future, the stock may have better days ahead. We have a natural aversion to companies that are losing money and shrinking revenue. But perhaps that is being too careful.

The chart below shows how revenue and earnings have changed with time, (if you click on the chart you can see the actual values).

NYSE:VNE Income Statement, June 11th 2019
NYSE:VNE Income Statement, June 11th 2019

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. So we recommend checking out this free report showing consensus forecasts

A Different Perspective

Given that the market gained 2.7% in the last year, Veoneer shareholders might be miffed that they lost 57%. While the aim is to do better than that, it’s worth recalling that even great long-term investments sometimes underperform for a year or more. With the stock down 31% over the last three months, the market doesn’t seem to believe that the company has solved all its problems. Given the relatively short history of this stock, we’d remain pretty wary until we see some strong business performance. It is all well and good that insiders have been buying shares, but we suggest you check here to see what price insiders were buying at.

Veoneer is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.